Quick Answer
Turn Therapeutics Inc. reported Operating Income of -$5.86 million for fiscal year 2025.
Turn Therapeutics Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$5.86M | -226.0% |
| 2024 | -$1.80M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.91M | -184.3% | -184.3% |
| September 30, 2024 | -$673.0K | — | — |
- Turn Therapeutics Inc. showed a decrease of -226.0% in Operating Income compared to the prior fiscal year.
- Over the 2024–2025 period, Turn Therapeutics Inc.’s operating income has declined by 226.0% (from -$1.80 million to -$5.86 million).
- The most recent figure is from Turn Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: